Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lung transplantation

S G Jenkinson1, S M Levine

  • 1University of Texas Health Science Center at San Antonio.

Disease-A-Month : DM
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Lung transplantation has advanced significantly, offering life-saving options for end-stage lung disease. This review covers surgical techniques, immunosuppression, and managing complications like rejection.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BK virus replication in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis.

American journal of nephrology·2014
Same author

Intracortical bone remodeling variation shows strong genetic effects.

Calcified tissue international·2013
Same author

Reproductive status and sex show strong effects on knee OA in a baboon model.

Osteoarthritis and cartilage·2013
Same author

Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2009
Same author

Osteopenia and osteoporosis in adult baboons (Papio hamadryas).

Journal of medical primatology·2008
Same author

Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2007
Same journal

Disturbances due to cold.

Disease-a-month : DM·2026
Same journal

GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review.

Disease-a-month : DM·2026
Same journal

GLP-1 receptor agonists for weight management and potential thromboembolic risk reduction in high risk population with cancer, diabetes, cardiovascular disease: A systematic review.

Disease-a-month : DM·2026
Same journal

Periodontal disease and diabetic kidney disease: A comprehensive analysis.

Disease-a-month : DM·2026
Same journal

Foreword for Glucagon-like peptide-1 receptor agonists (GLP-1) and its promise for potential benefits.

Disease-a-month : DM·2026
Same journal

Foreword for insulin autoimmune syndrome (Hirata Disease): An updated review of epidemiology, pathophysiology, clinical features, diagnosis, and management.

Disease-a-month : DM·2026
See all related articles

Area of Science:

  • Medicine
  • Surgery
  • Pulmonology

Background:

  • Lung transplantation has evolved from early unsuccessful attempts to current successful procedures for end-stage lung diseases.
  • Historical challenges included lung rejection, anastomotic issues, and infections, which have been progressively overcome.

Purpose of the Study:

  • To provide a comprehensive review of lung transplantation.
  • To discuss various aspects including surgical techniques, immunosuppression, graft preservation, and patient selection.

Main Methods:

  • Review of historical data and current practices in lung transplantation.
  • Discussion of immunosuppressive strategies, graft preservation methods, and surgical approaches (single vs. double lung).

Main Results:

Related Experiment Videos

  • Successful heart-lung transplantation in the 1980s paved the way for single and double lung transplants.
  • Current practices involve detailed recipient/donor selection, advanced surgical techniques, and comprehensive postoperative care.

Conclusions:

  • Lung transplantation is a viable treatment for end-stage pulmonary diseases.
  • Managing complications such as acute/chronic rejection and infections remains critical for long-term success.